M
(f; PH2); Enterosis (f; PH2); Epilepsy (f; MAD); Fever (f; MAD); Gallstone (f; MAD); Gas (f;
MAD; PH2; PNC); Gastrosis (f; PH2); Gout (f; MAD); Hepatosis (f; JLH); Induration (f; JLH);
Infection (f; MAD); Insomnia (f; HHB; MAD; PH2); Ischiosis (f; MAD); Kidney Stone (f; MAD);
Malaria (f; MAD); Nervousness (f; HHB; PH2); Rheumatism (f; MAD); Roemheld Syndrome (f;
PH2); Splenosis (f; JLH; MAD); Stomachache (f; MAD); Stone (f; MAD); Tuberculosis (f; MAD);
Uterosis (f; MAD); Water Retention (f; MAD; PH2); Worm (f; MAD).
Dosages (Masterwort) — 1 tsp (ca 4.5 g) root in cold infusion (MAD); 500–2000 mg powdered
root 2–3 ×/day (MAD; PH2); 4–8 ml liquid rhizome extract (PNC).
Contraindications, Interactions, and Side Effects (Masterwort) — Not covered (AHP). “Haz-
ards and/or side effects not known for proper therapeutic dosages” (PH2). Furanocoumarins may
be phototoxic (PH2; PNC).
MASTIC (Pistacia lentiscus L.) +Activities (Mastic) — Allergenic (f; CRC); Analgesic (f; BIB; CRC); Antibacterial (1; HH3);
Antisarcomic (1; HH3); Antiseptic (1; HH3); Antitumor (1; HH3); Antitussive (f; BIB; CRC);
Antiulcer (1; HH3; PH2); Aperitif (f; CRC); Aphrodisiac (f; CRC; DEP; EFS); Astringent (1; EFS;
PHR; PH2); Candidicide (1; HH3); Carminative (f; CRC); Depilatory (f; BIB); Diaphoretic (f;
CRC; EFS); Diuretic (f; CRC; DEP; EFS; HH3); Expectorant (f; CRC; EFS); Fungicide (f; HH3);
Hemostat (f; CRC; EFS); Hypotensive (f; HH3); Laxative (f; CRC; FDA); Masticatory (1; CRC);
Stimulant (f; DEP; EFS; HH3); Stomachic (f; CRC; EFS).
Indications (Mastic) — Adenopathy (f; JLH); Anorexia (f; CRC); Aposteme (f; CRC; JLH); Bacteria
(1; HH3); Bleeding (f; CRC; EFS); Blennorrhea (f; CRC); Boil (f; BIB; CRC); Bronchosis (f; FEL);
Cancer (1; CRC; HH3; JLH); Cancer, anus (f; CRC; JLH); Cancer, breast (f; CRC; JLH); Cancer, liver
(f; CRC; JLH); Cancer, parotid (f; CRC; JLH); Cancer, spleen (f; CRC; JLH); Cancer, stomach (f; CRC;
JLH); Cancer, testicle (f; CRC; JLH); Cancer, throat (f; CRC; JLH); Cancer, uterus (f; CRC; JLH);
Candida (1; HH3); Canker (f; BIB; CRC); Carbuncle (f; CRC); Caries (f; CRC; FEL); Catarrh (f; CRC;
FEL; HH3); Cholecystosis (f; BIB; CRC); Cirrhosis (f; CRC; HH3); Condyloma (f; CRC; JLH);
Constipation (f; CRC; FDA); Cough (f; BIB); Debility (f; CRC); Diarrhea (f; CRC; HH3); Dysentery
(f; CRC; HH3); Escherichia (1; HH3); Fever (f; CRC; EFS); Fungus (f; HH3); Gas (f; CRC); Gastrosis
(f; BIB; CRC); Gingivosis (1; FEL; PHR; PH2); Gonorrhea (f; CRC; HH3); Gout (f; HH3); Halitosis
(f; BIB; CRC; DEP; FEL; PHR); Heart (f; CRC); Hepatosis (f; BIB; CRC; HH3); High Blood Pressure
(f; HH3); Induration (f; CRC; JLH); Infection (f; HH3); Inflammation (f; JLH); Itch (f; BIB); Leukorrhea
(f; CRC; HH3); Mastosis (f; CRC); Mucososis (f; CRC); Mycosis (f; HH3); Nephrosis (f; FEL); Pain
(f; BIB; CRC); Phymata (f; CRC); Rheumatism (f; BIB; HH3); Sclerosis (f; CRC); Scirrhus (f; CRC;
JLH); Sore (f; HH3); Staphylococcus (1; HH3); Toothache (f; CRC); Tumor (1; CRC; HH3); Ulcer (1;
HH3; PH2); VD (f; CRC; HH3); Water Retention (f; CRC; DEP; EFS; HH3); Yeast (1; HH3).
Dosages (Mastic) — 150 ml 10% aqueous resin decoction/day (HH3).
Contraindications, Interactions, and Side Effects (Mastic) — Not covered (AHP). “Hazards
and/or side effects not known for proper therapeutic dosages” (PH2) (but PH2 designates no specific
quantified dosage! JAD).
Extracts (Mastic) — Ethanolic extracts are antiseptic and bactericidal at 1 g/l, candidicidal at >1 g/l.
Decoction kills Candida parapsilopsis, Escherichia, Sarcina, and Staphylococcus at 312 mg/L, Can-
dida albicans and Cryptococcus at 625 mg/L (HH3). Lyophilized aqueous extracts hypotensive in
normotensive rats as 25 mg/kg orally. Tannins, especially ellagitannins, arrested tumor growth (5–10
mg/kg ipr mouse) (HH3). LD50 of the lyophilized aqueous extract 680–1120 mg/kg ipr mouse (HH3).